PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions
Existing HT CBB Kit Enables High-Throughput Extraction of HMW DNA Tailored for HiFi With an Updated Workflow for Animal Blood and Bacteria
MENLO PARK, Calif., Jan. 15, 2024 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced PanDNA, a versatile Nanobind DNA extraction kit. This new offering expands the array of sample types suitable for long-read sequencing, including cells, bacteria, blood, tissue, plant nuclei, and insects.
Related news for (PACB)
- MoBot alert highlights: NASDAQ: IMCC, NASDAQ: BIAF, NASDAQ: HOLO, NYSE: JOBY, NASDAQ: PACB (05/28/25 02:00 PM)
- Breaking News: MoBot’s Latest Update as of 04/09/25 09:00 AM
- Today’s Top Performers: MoBot’s Market Review 02/14/25 09:00 AM
- PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
- PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024